LL-37 5 MG

LL-37 is a human antimicrobial peptide belonging to the cathelicidin family, playing a central role in innate immunity by directly targeting bacteria, fungi, and viruses as well as modulating immune responses. It is extensively studied in research for its multifunctional roles including antimicrobial activity, immune regulation, angiogenesis, and involvement in cancer biology.

Research involving LL-37 commonly explores:

• Its antimicrobial properties against a broad spectrum of pathogens including antibiotic-resistant strains.
• Modulation of inflammation and immune cell activation, linking host defense with tissue repair mechanisms.
• Promotion of angiogenesis and blood vessel formation in both physiological and pathological conditions.
• Complex roles in cancer, where LL-37 can either suppress or promote tumor growth depending on cancer type, and its potential as an immunostimulatory agent in cancer therapy.
• Its involvement in host defense and tissue regeneration with implications in infection control, wound healing, and immune modulation.
LL-37 has also been investigated for combination therapies and therapeutic targeting in conditions such as infections, chronic inflammation, and cancer.
LL-37 is provided as a lyophilized powder for laboratory research use only (RUO), not intended for clinical or diagnostic use in humans or animals.

Product details:

• Synonyms: Human cathelicidin LL-37, hCAP-18 fragment
• Purity: ≥95%-98%
• CAS Number: 211949-83-6
• Molecular Formula: C157H273N49O42
• Molecular Weight: Approximately 4493 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.